| Dec 21 | Dec 16 | Dec 15 | Dec 14 | Dec 13 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ -10.17M | $ 1.14M | $ 6.82M | $ 5.74M | $ 2.65M |
| Operating Income | $ 6.11M | $ -28.35M | $ -39.29M | $ -36.14M | $ -20.03M |
| EBITDA | $ 148.27M | $ -28.43M | $ -37.21M | $ -34.73M | $ -19.30M |
| Net Income | $ 143.07M | $ -31.04M | $ -37.80M | $ -34.75M | $ -19.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 59.34M | $ 67.77M | $ 85.74M | $ 72.90M | $ 58.47M |
| Total Debt | $ 4.56M | $ 34.56M | $ 23.11M | $ 2.63M | $ 2.56M |
| Net Debt | $ -4.97M | $ 13.76M | $ -9.22M | $ -50.70M | $ -38.31M |
| Total Liabilities | $ 149.08M | $ 53.79M | $ 42.63M | $ 8.07M | $ 9.14M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -62.42M | $ -25.46M | $ -35.05M | $ -36.12M | $ -21.63M |
| Operating Cash Flow | $ -62.10M | $ -25.20M | $ -33.80M | $ -34.37M | $ -17.75M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Lombard Medical (EVARF)
OTHER OTC:EVARF
